Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer ; volume:9 ; number:1 ; day:23 ; month:10 ; year:2009 ; pages:1-13 ; date:12.2009
BMC cancer ; 9, Heft 1 (23.10.2009), 1-13, 12.2009
- Creator
-
Merritt, Melissa A.
- Contributor
-
Parsons, Peter G.
Newton, Tanya R.
Martyn, Adam C.
Webb, Penelope M.
Green, Adèle C.
Papadimos, David J.
Boyle, Glen M.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-9-378
- URN
-
urn:nbn:de:1111-2016030352281
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Merritt, Melissa A.
- Parsons, Peter G.
- Newton, Tanya R.
- Martyn, Adam C.
- Webb, Penelope M.
- Green, Adèle C.
- Papadimos, David J.
- Boyle, Glen M.
- SpringerLink (Online service)
Other Objects (12)
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma
Low-grade Serous Ovarian Carcinoma
Notch signaling in serous ovarian cancer
Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
Benign serous ovarian tumour: a redefining moment?
A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours
Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer
High-grade serous ovarian cancer: the clone wars
Proteome profiling of low grade serous ovarian cancer
Prediction of chemo-response in serous ovarian cancer
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma
Low-grade Serous Ovarian Carcinoma
Notch signaling in serous ovarian cancer
Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
Benign serous ovarian tumour: a redefining moment?
A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours
Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer
High-grade serous ovarian cancer: the clone wars
Proteome profiling of low grade serous ovarian cancer
Prediction of chemo-response in serous ovarian cancer
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma
Low-grade Serous Ovarian Carcinoma
Notch signaling in serous ovarian cancer
Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
Benign serous ovarian tumour: a redefining moment?
A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours
Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer
High-grade serous ovarian cancer: the clone wars
Proteome profiling of low grade serous ovarian cancer